Matches in Wikidata for { <http://www.wikidata.org/entity/Q44067889> ?p ?o ?g. }
- Q44067889 description "2002 nî lūn-bûn" @default.
- Q44067889 description "2002年の論文" @default.
- Q44067889 description "2002年学术文章" @default.
- Q44067889 description "2002年学术文章" @default.
- Q44067889 description "2002年学术文章" @default.
- Q44067889 description "2002年学术文章" @default.
- Q44067889 description "2002年学术文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002年學術文章" @default.
- Q44067889 description "2002년 논문" @default.
- Q44067889 description "article científic" @default.
- Q44067889 description "article scientific" @default.
- Q44067889 description "article scientifique (publié 2002)" @default.
- Q44067889 description "articol științific" @default.
- Q44067889 description "articolo scientifico" @default.
- Q44067889 description "artigo científico (publicado na 2002)" @default.
- Q44067889 description "artigo científico (publicado na 2002)" @default.
- Q44067889 description "artigo científico" @default.
- Q44067889 description "artikull shkencor" @default.
- Q44067889 description "artikulong pang-agham" @default.
- Q44067889 description "artykuł naukowy" @default.
- Q44067889 description "artículo científico publicado en 2002" @default.
- Q44067889 description "artículu científicu espublizáu en 2002" @default.
- Q44067889 description "bilimsel makale" @default.
- Q44067889 description "bài báo khoa học" @default.
- Q44067889 description "mokslinis straipsnis" @default.
- Q44067889 description "naučni članak" @default.
- Q44067889 description "scienca artikolo" @default.
- Q44067889 description "scientific article" @default.
- Q44067889 description "teaduslik artikkel" @default.
- Q44067889 description "tieteellinen artikkeli" @default.
- Q44067889 description "tudományos cikk" @default.
- Q44067889 description "vedecký článok" @default.
- Q44067889 description "vetenskaplig artikel" @default.
- Q44067889 description "videnskabelig artikel (udgivet 2002)" @default.
- Q44067889 description "vitenskapelig artikkel" @default.
- Q44067889 description "vitskapeleg artikkel" @default.
- Q44067889 description "vědecký článek" @default.
- Q44067889 description "wetenschappelijk artikel" @default.
- Q44067889 description "wissenschaftlicher Artikel" @default.
- Q44067889 description "επιστημονικό άρθρο" @default.
- Q44067889 description "мақолаи илмӣ" @default.
- Q44067889 description "мақолаи илмӣ" @default.
- Q44067889 description "наукова стаття, опублікована в червні 2002" @default.
- Q44067889 description "научна статия" @default.
- Q44067889 description "научная статья" @default.
- Q44067889 description "научни чланак" @default.
- Q44067889 description "научни чланак" @default.
- Q44067889 description "գիտական հոդված" @default.
- Q44067889 description "מאמר מדעי" @default.
- Q44067889 description "سائنسی مضمون" @default.
- Q44067889 description "مقالة علمية" @default.
- Q44067889 description "مقالهٔ علمی" @default.
- Q44067889 description "২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q44067889 description "บทความทางวิทยาศาสตร์" @default.
- Q44067889 description "სამეცნიერო სტატია" @default.
- Q44067889 name "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 name "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 type Item @default.
- Q44067889 label "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 label "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 prefLabel "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 prefLabel "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 P1433 Q44067889-2F753EB0-BE29-4766-9686-E979B211B4BD @default.
- Q44067889 P1476 Q44067889-E8CDD654-6DB9-42DE-BEFD-6FFCCE0DEF8B @default.
- Q44067889 P2093 Q44067889-1474D2FC-9C23-42E4-890B-750EBD887B78 @default.
- Q44067889 P2093 Q44067889-48401B5F-B14E-4184-9570-51C5D380868C @default.
- Q44067889 P2093 Q44067889-484072FA-DA09-4898-8961-D9B912C08814 @default.
- Q44067889 P2093 Q44067889-5489F8B8-FEFD-49C3-A7D7-71FFCBD58F77 @default.
- Q44067889 P2093 Q44067889-6676BA6F-240B-447B-A9A3-B21D3991D91B @default.
- Q44067889 P2093 Q44067889-69A91824-5125-4ADC-81A1-BE3BBAE35666 @default.
- Q44067889 P2093 Q44067889-7123D00D-EEC9-4BC0-97BE-FF2171AB55A3 @default.
- Q44067889 P2093 Q44067889-86D38985-7C46-41B4-A857-6665794846CB @default.
- Q44067889 P2093 Q44067889-B43BF78B-6D36-439E-B3CB-F9135A871461 @default.
- Q44067889 P2093 Q44067889-C2D4D74B-BC6F-47A2-9D62-E34329F9A547 @default.
- Q44067889 P2093 Q44067889-D8AF5002-C14C-4C55-AE41-C794CF62D070 @default.
- Q44067889 P2093 Q44067889-EF504700-5FDD-4DF9-8DBB-DF59BC2F52FB @default.
- Q44067889 P304 Q44067889-BE2E7A3F-119F-4AA4-8031-14E36615406D @default.
- Q44067889 P31 Q44067889-01B6E101-E3AF-4D27-8684-A1C0A1DDD50A @default.
- Q44067889 P356 Q44067889-ED03A349-71A5-4A56-8416-31AF6583F667 @default.
- Q44067889 P433 Q44067889-0CBF7DA9-8A56-46B0-8E21-3020376A99CD @default.
- Q44067889 P478 Q44067889-9E70CA2B-E807-45EB-9BF8-469EA7DA9396 @default.
- Q44067889 P577 Q44067889-D74E5CF3-1D7F-4521-8257-2384F76BB89C @default.
- Q44067889 P698 Q44067889-9B092DDA-A521-4ACA-B5F1-EB5B1191E878 @default.
- Q44067889 P921 Q44067889-728CD340-7FA5-4A0F-9789-6824B2CE1445 @default.
- Q44067889 P921 Q44067889-75AAC3F6-3B30-4D13-AE10-DC38E96360DE @default.
- Q44067889 P921 Q44067889-E6FB47B5-5C6C-4D25-8ADE-DFCCB7B03978 @default.
- Q44067889 P356 MDF157 @default.
- Q44067889 P698 12123337 @default.
- Q44067889 P1433 Q326122 @default.
- Q44067889 P1476 "EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer" @default.
- Q44067889 P2093 "A Awada" @default.
- Q44067889 P2093 "A Hamilton" @default.
- Q44067889 P2093 "D de Valeriola" @default.
- Q44067889 P2093 "I Van Hoorebeeck" @default.
- Q44067889 P2093 "L Beex" @default.